Top

Published in:

Open Access 01-12-2024 | Acute Myeloid Leukemia | Correction

Correction: A chest CT-based nomogram for predicting survival in acute myeloid leukemia

Authors: Xiaoping Yi, Huien Zhan, Jun Lyu, Juan Du, Min Dai, Min Zhao, Yu Zhang, Cheng Zhou, Xin Xu, Yi Fan, Lin Li, Baoxia Dong, Xinya Jiang, Zeyu Xiao, Jihao Zhou, Minyi Zhao, Jian Zhang, Yan Fu, Tingting Chen, Yang Xu, Jie Tian, Qifa Liu, Hui Zeng

Published in: BMC Cancer | Issue 1/2024

Excerpt

Correction: BMC Cancer (2024) 24:458 …

Yi X, Zhan H, Lyu J, et al. A chest CT-based nomogram for predicting survival in acute myeloid leukemia. BMC Cancer. 2024;24:458. https://doi.org/10.1186/s12885-024-12188-8.CrossRefPubMedPubMedCentral

Title: Correction: A chest CT-based nomogram for predicting survival in acute myeloid leukemia
Authors: Xiaoping Yi
Huien Zhan
Jun Lyu
Juan Du
Min Dai
Min Zhao
Yu Zhang
Cheng Zhou
Xin Xu
Yi Fan
Lin Li
Baoxia Dong
Xinya Jiang
Zeyu Xiao
Jihao Zhou
Minyi Zhao
Jian Zhang
Yan Fu
Tingting Chen
Yang Xu
Jie Tian
Qifa Liu
Hui Zeng
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Acute Myeloid Leukemia
Published in: BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-024-12323-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Utility and predictive value of the CRAFITY score in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus tyrosine kinase inhibitors and PD-1 inhibitor

High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade

Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma

CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme

Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum

Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer